RxDoctor Payments Data

Robert Altman, MD

Clinical Cardiac Electrophysiology · Berkeley Heights, NJNPI 1588788814

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,357 of the $3,807 with a category attached, or 61.9%. 8 manufacturers reported payments, led by Biosense Webster, Inc. at 35.3% of the total. Reporting peaked in 2021 at $1,665 and has fallen 65.8% since, to $569 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in NJ, where the typical reported total is $15,131.

$3,807in general payments, 2019–2025

Across 37 payments — averaging $102.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biosense Webster, Inc.$1K
  • Boston Scientific$1K
  • Medtronic$929
  • Merz North America, Inc.$251
  • Impulse Dynamics (USA) Inc.$116
  • Abbott$43
  • plus $46 from 2 others
$4,115in research payments, 2019–2025

Across 9 payments — averaging $457.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$4K

What the payments were for

  • Consulting fees$70018%
  • Speaking & faculty fees$75020%
  • Food & beverage$2,35762%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,807 in reported general payments places this provider in the 15th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.

See all clinical cardiac electrophysiology providers in New Jersey →

Medicare billing

Part B allowed, 2024
$507,425
Medicare patients
1,265
Services billed
6,338

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban310$356,249
MultaqDronedarone Hcl74$103,868
XareltoRivaroxaban67$80,456
Dofetilide49$8,678
Metoprolol Succinate196$3,360
Amiodarone Hcl67$2,713
Flecainide Acetate59$2,361
Diltiazem 24hr Er (Cd)Diltiazem Hcl32$1,148
SotalolSotalol Hcl12$320

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Berkeley Heights

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →